Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 456

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 3
Chunk 456
---
295,526

(1)Of such amount, Mr. King and Mr. Lytle have agreed to defer 85% of their base salary payable in cash until
such a time that the Company is able to raise at least $4 million in funding.

(2)Of the 15% to be paid in cash, $17,308 has been accrued and not paid as of December 31, 2024.

(3)Of the 15% to be paid in cash, $8,862 has been accrued and not paid as of December 31, 2024.

(4)Effective June 1, 2024, Mr. Lytle reduced his time commitment to the Company to part-time status to provide
no more than eight (8) hours of service per month.

Outstanding Equity Awards

The following table sets forth certain information
regarding unexercised stock options and unvested stock awards held by our named executive officers as of December 31, 2024:

    Option Awards
     
    Stock Awards
  
    Name

    Grant
    Date

    Number of
    Securities
    Underlying
    Unexercised
    Options (#)
    Exercisable

    Number of
    Securities
    Underlying Unexercised
    Options (#) Unexercisable(1)

    Option
    Exercise
    Price ($)

    Option
    Expiration
    Date
     
    Number of Shares or Units of Stock That Have Not Vested (#)
     
    Market Value of Shares or Units of Stock That Have Not Vested ($)(3)
  
    Steven King
     
    12/16/2020(1)
     
    –
     
    –
     
    –
     
    –
     
    65,218
     
    45,653

    12/16/2020(2)
     
    –
     
    –
     
    –
     
    –
     
    43,479
     
    30,435
  
    Paul Lytle 
     
    12/16/2020(1)
     
    –
     
    –
     
    –
     
    –
     
    42,392
     
    29,674

    12/16/2020(2)
     
    –
     
    –